Bristol-Myers Squibb

Bristol-Myers Squibb Company (BMS) is a renowned American multinational pharmaceutical company headquartered in New York City. It holds a prominent position among the world's largest pharmaceutical companies and consistently appears on the prestigious Fortune 500 list of the largest U.S. corporations. In fiscal 2022, BMS achieved an impressive total revenue of $46.2 billion.

At Bristol Myers Squibb, the focus lies on the production of prescription pharmaceuticals and biologics across multiple therapeutic areas. These encompass crucial fields such as cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.

The company's primary research and development (R&D) facilities are strategically situated in Lawrence, New Jersey (formerly Squibb, near Princeton), Summit, New Jersey (previously the headquarters of Celgene), New Brunswick, New Jersey, Redwood City, California, and Seville, Spain. In addition to these sites, BMS maintains a presence in Devens and Cambridge, Massachusetts, East Syracuse, New York, Braine-l'Alleud, Belgium, Tokyo, Japan, Bangalore, India, and Wirral, United Kingdom. It is worth noting that Bristol-Myers previously operated an R&D site in Wallingford, Connecticut.

Bristol-Myers Squibb's extensive R&D network underscores its commitment to innovation and scientific advancement in the pharmaceutical industry. The company strives to develop groundbreaking treatments and therapies that can positively impact global healthcare through these strategically located facilities.

Founded: 1887

Headquarters: New York City, New York, U.S.

Website: https://www.bms.com/